John T. Schiller
Laboratory of Cellular Oncology
The Center for Cancer Research
United States of America
Biography
Dr. Schiller graduated from the University of Wisconsin-Madison with a B.S. in molecular biology in 1975. In 1982, he received a Ph.D. from the Department of Microbiology of the University of Washington in Seattle, then joined the Laboratory of Cellular Oncology as a National Research Service Award postdoctoral fellow in 1983. Dr. Schiller became a senior staff fellow in the Laboratory of Cellular Oncology in 1986 and a senior investigator in 1992. He became chief of the Neoplastic Disease Section of the lab in 1998, deputy lab chief in 2000 and designated as an NIH Distinguished Investigator in 2016. Dr. Schiller has received numerous awards for his contributions to papillomavirus virus molecular biology and HPV vaccine development, including the 2007 Service to America Medal – Federal Employee of the Year, the 2011 Albert Sabin Gold Medal Award, the 2011 AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention, the 2014 National Medal of Technology and Innovation, and the 2017 American Society for Microbiology’s Joseph Public Health Award.
Research Interest
Immunology, Molecular Biology and Biochemistry, Virology
Publications
-
Strain-specific properties and T cells regulate the susceptibility to papilloma induction by Mus musculus papillomavirus 1. Handisurya A, Day PM, Thompson CD, Bonelli M, Lowy DR, Schiller JT. PLoS Pathog. 10: e1004314, 2014.
-
A Cell-Free Assembly System for Generating Infectious Human Papillomavirus 16 Capsids Implicates a Size Discrimination Mechanism for Preferential Viral Genome Packaging. Cerqueira C, Pang YY, Day PM, Thompson CD, Buck CB, Lowy DR, Schiller JT. J Virol. 90: 1096-1107, 2015
-
Human papillomavirus capsids preferentially bind and infect tumor cells. Kines RC, Cerio RJ, Roberts JN, Thompson CD, de Los Pinos E, Lowy DR, Schiller JT. Int J Cancer. 138: 901-911, 2016
